Maine CDC Health Advisory
| Alert | Date | Details |
|---|
Update on Fungal Infections Outbreak and FDA Recall |
October 18, 2012 |
Word
PDF |
| The U.S. Centers for Disease Control and Prevention (US CDC) and the Food and Drug Administration (FDA) are coordinating a multi-state investigation of fungal meningitis and septic arthritis among patients who received steroid injections with potentially contaminated methylprednisolone acetate, produced by New England Compounding Center (NECC) located in Massachusetts. As of October 17, 2012, 247 cases (including 2 peripheral joint infections) and 19 deaths have been reported in 15 states. Maine did not receive any medication from the 3 recalled lots. |
Maine Center for Disease Control and Prevention, 286 Water Street, State House Station 11, Augusta, ME 04333-0011
General Information / Receptionist: 287-8016, TTY: 800-606-0215,
email contact for questions